© 2021 MJH Life Sciences and Consultant Live. All rights reserved.
June 09, 2021
A systematic review of clinical trials notes that topical eye drops may lead to favorable retinal and visual outcomes, despite heterogeneity across multiple studies.
June 04, 2021
The indication makes the Novo Nordisk product the first weekly injection GLP-1 agonist approved for managing overweight and obesity.
May 27, 2021
The EMDAC voted 10-7 to support the benefit-risks of teplizumab for delaying clinical type 1 diabetes.
May 16, 2021
The SGLT-2 inhibitor drug class is expanding into treatment indications experts could not have predicted. Learn how DAPA-HF contributed to the understanding of dapagliflozin.
May 12, 2021
Bayer has submitted a New Drug Application for the mineralocorticoid receptor antagonist.
May 11, 2021
The smart pen cap system is associated with real-time hypoglycemia alerts and insulin dose recommendations.
May 08, 2021
Research at ARVO 2021 highlighted a gamut of interplaying diabetes and vision loss risk factors, and even treatments for both. But experts depict a referral and care process that lacks whole diabetes care.
May 06, 2021
A new study finds the top 10 future research priorities into diabetes and pregnancy.
May 05, 2021
A discussion with an investigator on how the SGLT-2 inhibitor may help affected patients.
New data show dasiglucagon a reliable and rapid treatment in restoring plasma glucose levels.